Valeant Pharma (VRX) Updates on Generic Zovirax Approval; Sees Cash EPS Impact
Tweet Send to a Friend
Valeant Pharmaceuticals International, Inc. (NYSE: VRX) responded to a generic approval for Zovirax ointment.
"Yesterday, Mylan (Nasdaq: MYL) announced ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
"Yesterday, Mylan (Nasdaq: MYL) announced ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
